Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
News Focus
Saturn Oil & Gas Inc. Announces $525 Million Accretive Core-Area Saskatchewan Asset Acquisition (click to learn more) Safe Supply Streaming Portfolio Company Safety Strips, Provides Corporate Update (click to learn more)
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Kane Biotech Inc. V.KNE

Alternate Symbol(s):  KNBIF

Healthcare Biotechnology
Kane Biotech Inc. is a Canada-based biotechnology company. The Company is engaged in the research, development and commercialization of technologies and products that prevent and remove microbial biofilms. It has a portfolio of biotechnologies and products, which includes StrixNB, DispersinB, Aledex, bluestem, bluestem, silkstem, goldstem, coactiv+, coactiv+, DermaKB and DermaKB Biofilm. Its... see more

TSXV:KNE - Post Discussion

Kane Biotech Inc. > Hi all. What are realistic price targets here for the...
View:
Post by JimmyD on Apr 22, 2021 8:50pm

Hi all. What are realistic price targets here for the...

short term & long term? Also, a major NR soon? Thanks.
Comment by StoneMan45 on Apr 23, 2021 8:06am
short term likely a fairly sizeable jump up ...next 2 months most likely and I think at minimum we will see over .45 as the valuation placed on the initial jv to be formed is 70 mil and Kane will own 90% of that . The .45 min is only cause this is the determined valuation and who knows what the market will place on it. The truth is that this wound care deal is much much larger than that as it does ...more  
Comment by StoneMan45 on Apr 23, 2021 8:12am
the first bit  '..the initial jv to be formed is 70 million..' worded this poorly. It's the intial valuation on the wound care jv. There is already a jv for animal care with Animal Care ...STEM with an intial valuation of 15 million that should be up and running reasonably soon they were transferring manufacturing to Europe first. 
Comment by StoneMan45 on Apr 23, 2021 9:43am
damn... I said 1.2 million US for the milestone payments . Should be $500,000 US + $700,000 CND ...my bad
Kane Biotech Inc.